| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |